B. Riley has cut its price target for Core Scientific from $42 to $31 but still thinks it's a good buy.

CORZ · Core Scientific, Inc.

The AI's read

This is a change in one firm's view, not a report of a change in Core Scientific's business. The lower estimate points one way, but keeping its Buy rating points the other. With no company results or new business update in the story, neither side establishes a changed outlook.